Which of the following adverse effects is reported for evinacumab?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which of the following adverse effects is reported for evinacumab?

When evaluating adverse effects for evinacumab, the most likely and commonly reported issue is a reaction at the site of administration. Evinacumab is a human monoclonal antibody given by intravenous infusion, and protein-based therapies delivered this way often provoke local reactions at the infusion or injection site, such as redness, swelling, or discomfort. This makes an injection-site reaction the best-supported adverse effect among the options. Hypertension, nausea, and myalgia can occur with various medications but are not the characteristic or most commonly reported adverse effects for evinacumab.

When evaluating adverse effects for evinacumab, the most likely and commonly reported issue is a reaction at the site of administration. Evinacumab is a human monoclonal antibody given by intravenous infusion, and protein-based therapies delivered this way often provoke local reactions at the infusion or injection site, such as redness, swelling, or discomfort. This makes an injection-site reaction the best-supported adverse effect among the options.

Hypertension, nausea, and myalgia can occur with various medications but are not the characteristic or most commonly reported adverse effects for evinacumab.

More practice questions